The following are guidelines for evaluation and consideration for treatment of patients with inflammatory bone disease (IBD) after bone mineral density (BMD) measurements. The Crohn's & Colitis Foundation of America (CCFA) has indicated that its recommendations are intended to serve as reference points for clinical decision-making, not as rigid standards, limits, or rules. They should not be interpreted as quality standards.
No takes yet. Share an insight, caveat, or question.
Lichtenstein et al. (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: